Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Hemogenyx (HEMO) Share Price

Price 314.50p on 03-03-2025 at 06:00:04
Change 0.00p 0%
Buy 0.00p
Sell 0.00p
Buy / Sell HEMO Shares
Last Trade: Buy 150.00 at 316.50p
Day's Volume: 0
Last Close: 314.50p
Open: 0.00p
ISIN: GB00BQVXM815
Day's Range 0.00p - 0.00p
52wk Range: 0.876p - 420.00p
Market Capitalisation: £11m
VWAP: 0.00p
Shares in Issue: 4m

Hemogenyx (HEMO) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 150 316.50p Ordinary
14:52:21 - 28-Feb-25
Sell* 285 310.00p Automatic Execution
14:45:42 - 28-Feb-25
Sell* 16 310.00p Automatic Execution
14:45:30 - 28-Feb-25
Buy* 1 316.00p SI Trade
14:44:59 - 28-Feb-25
Buy* 1,450 316.50p Ordinary
14:40:57 - 28-Feb-25
Sell* 5 311.08p Ordinary
14:36:02 - 28-Feb-25
Buy* 90 316.50p Ordinary
14:17:01 - 28-Feb-25
Buy* 789 316.50p Ordinary
13:46:33 - 28-Feb-25
Buy* 462 316.70p Ordinary
13:02:31 - 28-Feb-25
Buy* 876 316.70p Ordinary
12:58:58 - 28-Feb-25
See more Hemogenyx trades

Hemogenyx (HEMO) Share Price History

Time period:
to
Date Open High Low Close Volume
3rd Mar 2025 (Mon) 314.50 314.50 314.50 314.50 0
28th Feb 2025 (Fri) 314.00 314.00 310.00 314.50 18,549
27th Feb 2025 (Thu) 315.00 315.00 295.00 307.00 23,283
26th Feb 2025 (Wed) 320.00 320.00 290.00 317.00 42,828
25th Feb 2025 (Tue) 343.00 344.00 330.00 329.50 14,558
24th Feb 2025 (Mon) 320.00 360.00 320.00 351.50 82,121
21st Feb 2025 (Fri) 310.00 319.00 310.00 317.50 16,907
20th Feb 2025 (Thu) 304.00 305.00 300.00 303.50 57,321
19th Feb 2025 (Wed) 324.00 324.00 275.00 290.50 80,248
18th Feb 2025 (Tue) 330.00 330.00 310.00 315.50 25,896
17th Feb 2025 (Mon) 337.00 339.50 337.00 339.50 1,645
14th Feb 2025 (Fri) 328.00 332.00 328.00 337.00 11,026
13th Feb 2025 (Thu) 333.00 333.00 333.00 338.50 2,533
12th Feb 2025 (Wed) 333.00 333.00 326.00 337.50 28,887
11th Feb 2025 (Tue) 349.00 349.00 335.00 340.00 4,095
10th Feb 2025 (Mon) 335.00 344.00 330.00 339.50 7,700
7th Feb 2025 (Fri) 340.00 340.00 336.00 347.50 3,423
6th Feb 2025 (Thu) 340.00 340.00 340.00 349.50 8,499
5th Feb 2025 (Wed) 341.00 341.00 335.00 345.00 10,908
4th Feb 2025 (Tue) 336.00 336.00 335.00 344.50 4,921
3rd Feb 2025 (Mon) 355.00 355.00 340.00 338.00 15,143
See more Hemogenyx price history

Hemogenyx (HEMO) Regulatory News

Date Source Headline
24th Feb 2025 7:00 am RNS First-in-Human Treatment with HG-CT-1
19th Feb 2025 4:50 pm RNS Issue of convertible loan notes
31st Jan 2025 9:35 am RNS Total Voting Rights
8th Jan 2025 7:00 am RNS Placing to raise £340,000
2nd Jan 2025 7:00 am RNS Change of Company Secretary and Registered Office
31st Dec 2024 7:00 am RNS Total Voting Rights
30th Dec 2024 7:00 am RNS Opening of First Clinical Site
19th Dec 2024 7:00 am RNS Ultrafast CAR-T Manufacturing
10th Dec 2024 4:10 pm RNS Admission of New Ordinary Shares and New ISIN
9th Dec 2024 1:30 pm RNS Result of Extraordinary General Meeting
See more Hemogenyx regulatory news

Hemogenyx (HEMO) Share News

IN BRIEF: Hemogenyx administers first human dose for leukemia therapy

24th Feb 2025 11:06

Hemogenyx Pharmaceuticals PLC - London-based biotechnology company - Administers its first in-human dose of HG-CT-1, the firm's proprietary CAR-T cell therapy, used in the treatment of relapsed or refractory acute myeloid leukemia in adults. Says further updates on the clinical trial will be provided "in due course". Read More

IN BRIEF: Hemogenyx Pharmaceuticals raises GBP340,000 for drug trial

8th Jan 2025 11:49

Hemogenyx Pharmaceuticals PLC - London-based biotechnology company - Says it has raised GBP340,000 through the placing of 100,000 shares at 340p each. The financing will be dedicated to the clinical trial of its HG-CT-1 drug, which is used for treatment of acute myeloid leukaemia in adults. The first patient for the trial has been recruited and is being tested to ensure they satisfy the clinic protocol. Read More

Hemogenyx opens first clinical site for leukaemia therapy trial

30th Dec 2024 12:01

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Monday reported the opening of the first clinical site in its HG-CT-1 phase 1 trial. Read More

TRADING UPDATES: SDX plots AIM exit; Celadon receives funds

6th Dec 2024 15:40

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

UK shareholder meetings calendar - next 7 days

2nd Dec 2024 13:32

Read More

See more Hemogenyx news
FTSE 100 Latest
Value8,809.74
Change0.00

Login to your account

Forgot Password?

Not Registered